Diabetes, Vol 47, Issue 9 1379-1383, Copyright © 1998 by American Diabetes Association

ARTICLES

Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis

RP Robertson
Pacific Northwest Research Institute, and Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle 98122, USA.

Dramatic, scientifically important discoveries in prostaglandin (PG) pharmacology and physiology have taken place over the past decade. Chief among these discoveries is the identification of two separate forms of cyclooxygenase (COX), a constitutive and an inducible form, both of which exist in most tissues. The pancreatic islet is an exception to this rule because it continually and dominantly expresses the inducible form, COX-2. It has also been learned that nonsteroidal anti-inflammatory drugs affect the two forms of COX with different potencies, a finding with far-reaching clinical implications. An equally important finding is that PGE2, which is known to negatively modulate glucose-induced insulin secretion, has at least four different subtypes of receptors with different mechanisms of action and metabolic consequences. These recent changes in our understanding of the molecular regulation of PG synthesis call for a reconsideration of previous hypotheses involving PGE2 as a regulator of beta-cell function in physiological and pathophysiological states.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. J. Persaud, D. Muller, V. D. Belin, I. Kitsou-Mylona, H. Asare-Anane, A. Papadimitriou, C. J. Burns, G. C. Huang, S. A. Amiel, and P. M. Jones The Role of Arachidonic Acid and Its Metabolites in Insulin Secretion From Human Islets of Langerhans Diabetes, January 1, 2007; 56(1): 197 - 203. [Abstract] [Full Text] [PDF]

				U. R. Mbonye, M. Wada, C. J. Rieke, H.-Y. Tang, D. L. DeWitt, and W. L. Smith The 19-amino Acid Cassette of Cyclooxygenase-2 Mediates Entry of the Protein into the Endoplasmic Reticulum-associated Degradation System J. Biol. Chem., November 24, 2006; 281(47): 35770 - 35778. [Abstract] [Full Text] [PDF]

				C. Shimamoto, Y. Nakanishi, K.-i. Katsu, T. Nakano, T. Kubota, H. Mori, and T. Nakahari Prostaglandin E2 release in gastric antral mucosa of guinea-pigs: basal PGE2 release by cyclo-oxygenase 2 and ACh-stimulated PGE2 release by cyclo-oxygenase 1 Exp Physiol, November 1, 2006; 91(6): 1015 - 1024. [Abstract] [Full Text] [PDF]

				H. Oshima, M. M. Taketo, and M. Oshima Destruction of Pancreatic beta-Cells by Transgenic Induction of Prostaglandin E2 in the Islets J. Biol. Chem., September 29, 2006; 281(39): 29330 - 29336. [Abstract] [Full Text] [PDF]

				A Juuti, J Louhimo, S Nordling, A Ristimaki, and C Haglund Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer J. Clin. Pathol., April 1, 2006; 59(4): 382 - 386. [Abstract] [Full Text] [PDF]

				M. E. Kimple, A. B. Nixon, P. Kelly, C. L. Bailey, K. H. Young, T. A. Fields, and P. J. Casey A Role for Gz in Pancreatic Islet {beta}-Cell Biology J. Biol. Chem., September 9, 2005; 280(36): 31708 - 31713. [Abstract] [Full Text] [PDF]

				R. Natarajan and J. L. Nadler Lipid Inflammatory Mediators in Diabetic Vascular Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1542 - 1548. [Abstract] [Full Text] [PDF]

				F. Yang and D. Bleich Transcriptional Regulation of Cyclooxygenase-2 Gene in Pancreatic {beta}-Cells J. Biol. Chem., August 20, 2004; 279(34): 35403 - 35411. [Abstract] [Full Text] [PDF]

				N. Shanmugam, I. T. Gaw Gonzalo, and R. Natarajan Molecular Mechanisms of High Glucose-Induced Cyclooxygenase-2 Expression in Monocytes Diabetes, March 1, 2004; 53(3): 795 - 802. [Abstract] [Full Text] [PDF]

				N. Shanmugam, Y. S. Kim, L. Lanting, and R. Natarajan Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for Advanced Glycation End Products J. Biol. Chem., September 12, 2003; 278(37): 34834 - 34844. [Abstract] [Full Text] [PDF]

				S. G. Laychock, Y. Tian, and S. M. Sessanna Endothelial Differentiation Gene Receptors in Pancreatic Islets and INS-1 Cells Diabetes, August 1, 2003; 52(8): 1986 - 1993. [Abstract] [Full Text] [PDF]

				T. Tabatabaie, A. Vasquez-Weldon, D. R. Moore, and Y. Kotake Free Radicals and the Pathogenesis of Type 1 Diabetes: {beta}-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2 Diabetes, August 1, 2003; 52(8): 1994 - 1999. [Abstract] [Full Text] [PDF]

				R. Han and T. J. Smith Cytoplasmic Prostaglandin E2 Synthase Is Dominantly Expressed in Cultured KAT-50 Thyrocytes, Cells That Express Constitutive Prostaglandin-endoperoxide H Synthase-2. BASIS FOR LOW PROSTAGLANDIN E2 PRODUCTION J. Biol. Chem., September 20, 2002; 277(39): 36897 - 36903. [Abstract] [Full Text] [PDF]

				X. Han, S. Chen, Y. Sun, J. L. Nadler, and D. Bleich Induction of Cyclooxygenase-2 Gene in Pancreatic {beta}-Cells by 12-Lipoxygenase Pathway Product 12-Hydroxyeicosatetraenoic Acid Mol. Endocrinol., September 1, 2002; 16(9): 2145 - 2154. [Abstract] [Full Text] [PDF]

				A. G. Gianoukakis, H. J. Cao, T. A. Jennings, and T. J. Smith Prostaglandin endoperoxide H synthase expression in human thyroid epithelial cells Am J Physiol Cell Physiol, March 1, 2001; 280(3): C701 - C708. [Abstract] [Full Text] [PDF]

				R. Day, B. Morrison, A. Luza, O. Castaneda, A. Strusberg, M. Nahir, K. B. Helgetveit, B. Kress, B. Daniels, J. Bolognese, et al. A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients With Osteoarthritis Arch Intern Med, June 26, 2000; 160(12): 1781 - 1787. [Abstract] [Full Text] [PDF]

				M. A. Molina, M. Sitja-Arnau, M. G. Lemoine, M. L. Frazier, and F. A. Sinicrope Increased Cyclooxygenase-2 Expression in Human Pancreatic Carcinomas and Cell Lines: Growth Inhibition by Nonsteroidal Anti-Inflammatory Drugs Cancer Res., September 1, 1999; 59(17): 4356 - 4362. [Abstract] [Full Text] [PDF]

				T. J. Smith, T. A. Jennings, D. Sciaky, and H. J. Cao Prostaglandin-endoperoxide H Synthase-2 Expression in Human Thyroid Epithelium. EVIDENCE FOR CONSTITUTIVE EXPRESSION IN VIVO AND IN CULTURED KAT-50 CELLS J. Biol. Chem., May 28, 1999; 274(22): 15622 - 15632. [Abstract] [Full Text] [PDF]

				K. Subbaramaiah, D. T. Lin, J. C. Hart, and A. J. Dannenberg Peroxisome Proliferator-activated Receptor gamma Ligands Suppress the Transcriptional Activation of Cyclooxygenase-2. EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1 AND CREB-BINDING PROTEIN/p300 J. Biol. Chem., April 6, 2001; 276(15): 12440 - 12448. [Abstract] [Full Text] [PDF]